Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.

Kim KJ, Baek IW, Park YJ, Yoon CH, Kim WU, Cho CS.

Int J Rheum Dis. 2015 Jun;18(5):524-32. doi: 10.1111/1756-185X.12262. Epub 2014 Jan 16.

PMID:
24428867
2.

Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

Castillo-Martínez D, Marroquín-Fabián E, Lozada-Navarro AC, Mora-Ramírez M, Juárez M, Sánchez-Muñoz F, Vargas-Barrón J, Sandoval J, Amezcua-Guerra LM.

Lupus. 2016 Jan;25(1):61-6. doi: 10.1177/0961203315600539. Epub 2015 Aug 24.

PMID:
26306740
3.

Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.

Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Tian Z, Liu Y, He J, Zhang F, Zhao Y, Zeng X; CSTAR co-authors.

Lupus. 2014 Sep;23(10):1085-91. doi: 10.1177/0961203314527366. Epub 2014 Mar 20.

PMID:
24651670
4.

Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus.

Prabu A, Patel K, Yee CS, Nightingale P, Situnayake RD, Thickett DR, Townend JN, Gordon C.

Rheumatology (Oxford). 2009 Dec;48(12):1506-11. doi: 10.1093/rheumatology/kep203. Epub 2009 Aug 11.

5.

Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.

Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C.

Autoimmun Rev. 2013 Jan;12(3):410-5. doi: 10.1016/j.autrev.2012.07.010. Epub 2012 Jul 25.

PMID:
22841984
6.

Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population.

Xia YK, Tu SH, Hu YH, Wang Y, Chen Z, Day HT, Ross K.

Rheumatol Int. 2013 May;33(5):1211-7. doi: 10.1007/s00296-012-2525-y. Epub 2012 Sep 16. Review.

7.

Pulmonary hypertension in systemic lupus erythematosus.

Shen JY, Chen SL, Wu YX, Tao RQ, Gu YY, Bao CD, Wang Q.

Rheumatol Int. 1999;18(4):147-51.

PMID:
10220835
8.

Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.

Kim KJ, Baek IW, Yoon CH, Kim WU, Cho CS.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1702-11. doi: 10.1002/acr.22630.

PMID:
26018410
9.

Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.

Min HK, Lee JH, Jung SM, Lee J, Kang KY, Kwok SK, Ju JH, Park KS, Park SH.

Korean J Intern Med. 2015 Mar;30(2):232-41. doi: 10.3904/kjim.2015.30.2.232. Epub 2015 Feb 27.

10.

Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival.

Hübbe-Tena C, Gallegos-Nava S, Márquez-Velasco R, Castillo-Martínez D, Vargas-Barrón J, Sandoval J, Amezcua-Guerra LM.

Rheumatology (Oxford). 2014 Jul;53(7):1256-63. doi: 10.1093/rheumatology/keu012. Epub 2014 Mar 5.

11.

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M.

Chest. 2006 May;129(5):1313-21.

PMID:
16685024
12.

Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.

Dimitroulas T, Giannakoulas G, Papadopoulou K, Sfetsios T, Karvounis H, Dimitroula H, Parcharidou D, Koliakos G, Garyfallos A, Styliadis I, Settas L.

Clin Rheumatol. 2010 Sep;29(9):957-64. doi: 10.1007/s10067-010-1494-3. Epub 2010 Jun 5.

PMID:
20526641
13.

B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?

Karadag O, Calguneri M, Yavuz B, Atalar E, Akdogan A, Kalyoncu U, Kiraz S, Aksoyek S, Ozmen F, Ertenli AI.

Clin Rheumatol. 2007 Oct;26(10):1701-4. Epub 2007 Feb 21.

PMID:
17318274
14.

Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Dimitroulas T, Giannakoulas G, Dimitroula H, Sfetsios T, Parcharidou D, Karvounis H, Settas L.

Rheumatol Int. 2011 Feb;31(2):263-7. doi: 10.1007/s00296-010-1557-4. Epub 2010 Jul 25.

PMID:
20658290
15.

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB.

Clin Rheumatol. 2006 Nov;25(6):866-72. Epub 2006 Feb 22.

PMID:
16496078
16.

Coronary artery dilation among patients with paediatric-onset systemic lupus erythematosus.

Shen CC, Chung HT, Huang YL, Yeh KW, Huang JL.

Scand J Rheumatol. 2012;41(6):458-65. doi: 10.3109/03009742.2012.694470. Epub 2012 Jul 24.

PMID:
22827323
17.

Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause.

Akdogan A, Kilic L, Dogan I, Okutucu S, Er E, Kaya B, Coplu L, Calguneri M, Tokgozoglu L, Ertenli I.

J Clin Rheumatol. 2013 Dec;19(8):421-5. doi: 10.1097/RHU.0000000000000037.

PMID:
24263143
18.

Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry.

Jeon CH, Chai JY, Seo YI, Jun JB, Koh EM, Lee SK; pulmonary hypertension study group of Korean College of Rheumatology.

Int J Rheum Dis. 2012 Oct;15(5):e80-9. doi: 10.1111/j.1756-185X.2012.01815.x. Epub 2012 Sep 27. Erratum in: Int J Rheum Dis. 2013 Dec;16(6):789.

PMID:
23083052
19.

Pulmonary arterial hypertension in SLE: what do we know?

Prabu A, Gordon C.

Lupus. 2013 Oct;22(12):1274-85. doi: 10.1177/0961203313505010.

PMID:
24098000
20.

[Pulmonary arterial hypertension in systemic lupus erythematosus].

Arnaud L, Agard C, Haroche J, Cacoub P, Piette JC, Amoura Z.

Rev Med Interne. 2011 Nov;32(11):689-97. doi: 10.1016/j.revmed.2011.01.002. Epub 2011 Mar 3. Review. French.

PMID:
21376432
Items per page

Supplemental Content

Write to the Help Desk